Gastrointestinal stromal tumor screening: Difference between revisions
Mahshid |
Akshun Kalia (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Gastrointestinal stromal tumor}} | {{Gastrointestinal stromal tumor}} | ||
{{CMG}};{{AE}}{{Akshun}} | |||
==Overview== | |||
There is insufficient evidence to recommend routine screening for [disease/malignancy]. | |||
OR | |||
According to the [guideline name], screening for [disease name] is not recommended. | |||
OR | |||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | |||
==Screening== | |||
*There is insufficient evidence to recommend routine screening for [disease/malignancy]. | |||
OR | |||
*According to the [guideline name], screening for [disease name] is not recommended. | |||
OR | |||
*According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with: | |||
**[Condition 1] | |||
**[Condition 2] | |||
**[Condition 3] | |||
==References== | ==References== | ||
Revision as of 16:35, 15 December 2017
|
Gastrointestinal stromal tumor Microchapters |
|
Differentiating Gastrointestinal stromal tumor from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Gastrointestinal stromal tumor screening On the Web |
|
American Roentgen Ray Society Images of Gastrointestinal stromal tumor screening |
|
Directions to Hospitals Treating Gastrointestinal stromal tumor |
|
Risk calculators and risk factors for Gastrointestinal stromal tumor screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
- There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
- According to the [guideline name], screening for [disease name] is not recommended.
OR
- According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]